Cortés-Vicente, E, Schreiner, B, Saccà, F, Narayanaswami, P. Editorial: New perspectives in the treatment of myasthenia gravis. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1418631. PMID:38919972. IF:2.800(Q2/5D).

Moreno-Martinez, ME, Riba, M, García-Cadenas, I, Esquirol, A, Yusta, M, Redondo, S, De Dios, A, Portos, JM, Aso, O, Marcos-Fendian, A, Font, N, Briones, J, Martino, R, Feliu, A. Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement. Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1397115. PMID:38919607. IF:5.900(Q1/2D).

Chiricozzi, A, Coscarella, G, Puig, L, Vender, R, Yeung, JS, Carrascosa, JM, Piaserico, S, Gisondi, P, Lynde, C, Ferreira, P, Bastos, PM, Dauden, E, Leite, L, Valerio, J, del Alcazar-Viladomiu, E, Vilarrasa, E, Llamas-Velasco, M, Alessandri-Bonetti, M, Messina, F, Bruni, M, Di Brizzi, EV, Ricceri, F, Nidegger, A, Hugo, J, Mufti, A, Daponte, AI, Teixeira, L, Balato, A, Romanelli, M, Prignano, F, Gkalpakiotis, S, Conrad, C, Lazaridou, E, Rompoti, N, Stratigos, AJ, Nogueira, M, Peris, K, Torres, T. Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(11)DOI:10.1111/jdv.20143. PMID:38860729. IF:8.000(Q1/1D).

Iznardo, H, López-Torija, I, Mateu-Arrom, L, Escribano-Sanz, P, Puig, L, Roé, E. Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant. PEDIATRIC DERMATOLOGY. 2024; 41(5)DOI:10.1111/pde.15675. PMID:38858093. IF:1.200(Q3/7D).

Gregorc, V, González-Cao, M, Salvagni, S, Koumarianou, A, Gil-Bazo, I, Maio, M, Viteri, S, Majem, M, Gutiérrez, V, Caro, RB, Sanmamed, MF, Zhu, HQ, Shen, HG, Wang, Y, Rosell, R. KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(17_SUPPL)DOI:10.1200/JCO.2024.42.17_suppl.LBA8511. PMID:. IF:41.900(Q1/1D).

Aarnink, EW, Maarse, M, Fierro, N, Mazzone, P, Beneduce, A, Tondo, C, Gasperetti, A, Pracon, R, Demkow, M, Zielinski, K, de Backer, O, Korsholm, K, Nielsen-Kudsk, JE, Estévez-Loureiro, R, Caneiro-Queija, B, Benito-González, T, de Prado, AP, Nombela-Franco, L, Salinas, P, Holmes, D, Almakadma, AH, Berti, S, Romeo, MR, Millan, X, Arzamendi, D, Alla, VM, Agarwal, H, Eitel, I, Paitazoglou, C, Freixa, X, Cepas-Guillén, P, Chothia, R, Badejoko, SO, Spoon, DB, Maddux, JT, El-Chami, M, Ram, P, Branca, L, Adamo, M, Suradi, HS, Peper, J, van Dijk, VF, Rensing, BJWM, Swaans, MJ, Vireca, E, Bergmann, MW, Boersma, LVA. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication. JACC-Cardiovascular Interventions. 2024; 17(11)DOI:10.1016/j.jcin.2024.04.012. PMID:38795093. IF:11.400(Q1/1D).

Porta-Casteràs, D, Vicent-Gil, M, Serra-Blasco, M, Navarra-Ventura, G, Solé, B, Montejo, L, Torrent, C, Martinez-Aran, A, de la Peña-Arteaga, V, Palao, D, Vieta, E, Cardoner, N, Cano, M. Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2024; 132DOI:10.1016/j.pnpbp.2024.110962. PMID:38365103. IF:3.900(Q1/2D).

Calderón, AT, Sans-Roselló, J, Fernández-Peregrina, E, Sánchez, JS, Bosch-Peligero, E, Sánchez-Ceña, J, Romero, JS, Valcárcel-Paz, D, Jiménez-Kockar, M, Gil, JLD, Asmarats, L, Millan-Alvarez, X, Vilchez-Tschischke, JP, Martinez-Rubio, A, Garcia-Garcia, HM. Impact of the use of plaque modification techniques on coronary microcirculation using an angiography-derived index of microcirculatory resistance. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING. 2024; 40(8)DOI:10.1007/s10554-024-03152-5. PMID:38848005. IF:1.500(Q3/7D).